Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Laryngeal Diseases × tremelimumab × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Prostatic Neoplasms 6 Diabetes Mellitus, Insulin-Dependent, 12 6 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Urinary Bladder Neoplasms 2 Recurrent Squamous Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Mesothelioma 2 Lung Neoplasms 2 Liver Neoplasms 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Testicular Neoplasms 1 Solid Tumor 1 Sarcoma, Synovial 1

Interventions

Cisplatin 3 Cetuximab 3 Pemetrexed 2 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2 Gemcitabine 2 pembrolizumab 1 monalizumab 1 durvalumab 1 X-Rays 1 Vitamin B 12 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Radiation 1 Proflavine 1 Paclitaxel 1 Metformin 1 Gefitinib 1 Gabapentin 1 Folic Acid 1 Fibroblast Growth Factor 7 1 Drug Therapy 1 Docetaxel 1 Chemical Fractionation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡